We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.8B
AUM Growth
-$159M
Cap. Flow
-$187M
Cap. Flow %
-3.89%
Top 10 Hldgs %
18.32%
Holding
695
New
64
Increased
242
Reduced
263
Closed
62

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$40.8M
2
INTU icon
Intuit
INTU
+$32.8M
3
META icon
Meta Platforms (Facebook)
META
+$30.3M
4
MA icon
Mastercard
MA
+$28.3M
5
NKE icon
Nike
NKE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 29.43%
2 Financials 13.37%
3 Technology 9.86%
4 Consumer Discretionary 7.77%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPC icon
401
Marathon Petroleum
MPC
$90.3B
$1.3M 0.03%
24,818
-12,004
-33% -$611K
FOSL icon
402
Fossil Group
FOSL
$239M
$1.28M 0.03%
18,430
-94,116
-84% -$7.31M
EQR icon
403
Equity Residential
EQR
$25.4B
$1.27M 0.03%
18,125
+604
+3% +$44.8K
DD
404
DELISTED
Du Pont De Nemours E I
DD
$1.26M 0.03%
20,841
-1,146
-5% -$77.2K
RDHL
405
Redhill Biopharma
RDHL
$3.85M
$1.25M 0.03%
71
CB
406
DELISTED
CHUBB CORPORATION
CB
$1.25M 0.03%
13,168
-86
-0.6% -$8.49K
HIG icon
407
Hartford Financial Services
HIG
$38.5B
$1.22M 0.03%
29,433
+3,001
+11% +$125K
MUR icon
408
Murphy Oil
MUR
$5.58B
$1.22M 0.03%
29,349
-86,214
-75% -$3.92M
DVAX
409
DELISTED
Dynavax Technologies
DVAX
$1.22M 0.03%
+52,000
New +$1.13M
SRPT icon
410
Sarepta Therapeutics
SRPT
$1.66B
$1.22M 0.03%
40,000
-30,000
-43% -$613K
BBWI icon
411
Bath & Body Works
BBWI
$4.01B
$1.21M 0.03%
17,400
-68,282
-80% -$4.9M
BIDU icon
412
Baidu
BIDU
$35.8B
$1.19M 0.02%
6,000
-3,420
-36% -$700K
ECL icon
413
Ecolab
ECL
$75.6B
$1.19M 0.02%
10,495
-129,643
-93% -$14.9M
URI icon
414
United Rentals
URI
$71.1B
$1.19M 0.02%
13,550
+5,880
+77% +$563K
SYY icon
415
Sysco
SYY
$39.7B
$1.17M 0.02%
32,286
+10,084
+45% +$377K
CHRS icon
416
Coherus Oncology
CHRS
$217M
$1.16M 0.02%
40,000
SPN
417
DELISTED
Superior Energy Services, Inc.
SPN
$1.14M 0.02%
5,430
-5,449
-50% -$1.28M
DISCK
418
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.14M 0.02%
36,735
-375,695
-91% -$11.6M
ED icon
419
Consolidated Edison
ED
$41.6B
$1.14M 0.02%
19,607
+8,200
+72% +$495K
RDY icon
420
Dr. Reddy's Laboratories
RDY
$9.82B
$1.11M 0.02%
100,000
+10,000
+11% +$110K
VRSK icon
421
Verisk Analytics
VRSK
$26.4B
$1.1M 0.02%
15,190
+9,480
+166% +$697K
PCAR icon
422
PACCAR
PCAR
$69.6B
$1.1M 0.02%
25,781
-73,525
-74% -$3.17M
CSX icon
423
CSX Corp
CSX
$98.6B
$1.09M 0.02%
100,656
-15,771
-14% -$183K
BTU
424
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$1.09M 0.02%
+33,333
New +$1.95M
TROW icon
425
T. Rowe Price
TROW
$25B
$1.09M 0.02%
14,034
+109
+0.8% +$8.8K

Similar funds

Candriam SCA's Q2 2015 Portfolio in Review

As of Q2 2015, Candriam SCA held 695 positions worth $4.8B, down 3.2% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $187M in Q2 2015, closing 62 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Japan ETF, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in American Airlines Group worth $11.6M.

  • Candriam SCA's largest Q2 2015 buy was American Airlines Group: 290,014 shares worth $11.6M.
  • Candriam SCA added most to Alphabet (Google) Class C in Q2 2015, an estimated $33.8M increase.
  • Candriam SCA's biggest Q2 2015 reduction was Intuit, cutting an estimated $32.8M.
  • Candriam SCA fully exited iShares MSCI Japan ETF in Q2 2015, selling an estimated $40.8M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.8B portfolio in Q2 2015.
  • Candriam SCA opened 64 new positions and closed 62 in Q2 2015.
  • Candriam SCA's portfolio value fell 3.2% quarter-over-quarter to $4.8B.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.